tiprankstipranks
Trending News
More News >
Kura Oncology (KURA)
NASDAQ:KURA

Compare Kura Oncology (KURA) vs. Competitors

Compare
790 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kura Oncology
$9.17
$797.95M
-3.72
27.21%
9 Buy
1 Hold
0 Sell
Strong Buy
Oruka Therapeutics
$30.69
$1.49B
-12.97
123.46%
11 Buy
0 Hold
0 Sell
Strong Buy
Phathom Pharmaceuticals
$14.47
$1.13B
-4.10
136.10%
5 Buy
1 Hold
0 Sell
Strong Buy
Keros Therapeutics
$18.88
$575.20M
12.64
52.11%
3 Buy
4 Hold
0 Sell
Moderate Buy
Tyra Bioscience
$28.77
$1.54B
-15.33
90.79%
5 Buy
0 Hold
0 Sell
Strong Buy
Septerna, Inc.
$24.88
$1.11B
-17.47
55.18%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KURA
Kura Oncology
9.21
1.95
26.86%
ORKA
Oruka Therapeutics
31.34
17.47
125.96%
PHAT
Phathom Pharmaceuticals
15.63
8.84
130.19%
KROS
Keros Therapeutics
19.50
7.02
56.25%
TYRA
Tyra Bioscience
28.81
12.87
80.74%
SEPN
Septerna, Inc.
26.38
9.42
55.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts